Literature DB >> 20176408

PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel.

Yong Zhang1, Meirong Huo, Jianping Zhou, Shaofei Xie.   

Abstract

This study presents PKSolver, a freely available menu-driven add-in program for Microsoft Excel written in Visual Basic for Applications (VBA), for solving basic problems in pharmacokinetic (PK) and pharmacodynamic (PD) data analysis. The program provides a range of modules for PK and PD analysis including noncompartmental analysis (NCA), compartmental analysis (CA), and pharmacodynamic modeling. Two special built-in modules, multiple absorption sites (MAS) and enterohepatic circulation (EHC), were developed for fitting the double-peak concentration-time profile based on the classical one-compartment model. In addition, twenty frequently used pharmacokinetic functions were encoded as a macro and can be directly accessed in an Excel spreadsheet. To evaluate the program, a detailed comparison of modeling PK data using PKSolver and professional PK/PD software package WinNonlin and Scientist was performed. The results showed that the parameters estimated with PKSolver were satisfactory. In conclusion, the PKSolver simplified the PK and PD data analysis process and its output could be generated in Microsoft Word in the form of an integrated report. The program provides pharmacokinetic researchers with a fast and easy-to-use tool for routine and basic PK and PD data analysis with a more user-friendly interface. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20176408     DOI: 10.1016/j.cmpb.2010.01.007

Source DB:  PubMed          Journal:  Comput Methods Programs Biomed        ISSN: 0169-2607            Impact factor:   5.428


  410 in total

1.  Phospho-NSAIDs have enhanced efficacy in mice lacking plasma carboxylesterase: implications for their clinical pharmacology.

Authors:  Chi C Wong; Ka-Wing Cheng; Ioannis Papayannis; George Mattheolabakis; Liqun Huang; Gang Xie; Nengtai Ouyang; Basil Rigas
Journal:  Pharm Res       Date:  2014-11-13       Impact factor: 4.200

2.  Noninvasive detection of passively targeted poly(ethylene glycol) nanocarriers in tumors.

Authors:  Yashveer Singh; Dayuan Gao; Zichao Gu; Shike Li; Stanley Stein; Patrick J Sinko
Journal:  Mol Pharm       Date:  2011-11-22       Impact factor: 4.939

3.  Paritaprevir and Ritonavir Liver Concentrations in Rats as Assessed by Different Liver Sampling Techniques.

Authors:  Charles S Venuto; Marianthi Markatou; Yvonne Woolwine-Cunningham; Rosemary Furlage; Andrew J Ocque; Robin DiFrancesco; Emily O Dumas; Paul K Wallace; Gene D Morse; Andrew H Talal
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

4.  Measurement of piperacillin plasma concentrations in cancer patients with suspected infection.

Authors:  Tobias Rachow; Verena Schlüter; Sibylle Bremer-Streck; Udo Lindig; Sebastian Scholl; Peter Schlattmann; Michael Kiehntopf; Andreas Hochhaus; Marie von Lilienfeld-Toal
Journal:  Infection       Date:  2017-05-17       Impact factor: 3.553

5.  Targeted PRINT Hydrogels: The Role of Nanoparticle Size and Ligand Density on Cell Association, Biodistribution, and Tumor Accumulation.

Authors:  Kevin G Reuter; Jillian L Perry; Dongwook Kim; J Christopher Luft; Rihe Liu; Joseph M DeSimone
Journal:  Nano Lett       Date:  2015-09-30       Impact factor: 11.189

6.  Specific targeting of neurotoxic side effects and pharmacological profile of the novel cancer stem cell drug salinomycin in mice.

Authors:  Wolfgang Boehmerle; Hanna Muenzfeld; Andreas Springer; Petra Huehnchen; Matthias Endres
Journal:  J Mol Med (Berl)       Date:  2014-04-27       Impact factor: 4.599

7.  Oral administration of lipid oil-in-water emulsions performed with synthetic or protein-type emulsifiers differentially affects post-prandial triacylglycerolemia in rats.

Authors:  Merian Nassra; Christine Bourgeois; Muriel Subirade; Patrick Sauvant; Claude Atgié
Journal:  J Physiol Biochem       Date:  2018-05-03       Impact factor: 4.158

8.  The pharmacokinetics and pharmacodynamics of mycophenolate mofetil in younger and elderly renal transplant recipients.

Authors:  Jiang-Tao Tang; Brenda C de Winter; Dennis A Hesselink; Ferdi Sombogaard; Lan-Lan Wang; Teun van Gelder
Journal:  Br J Clin Pharmacol       Date:  2016-11-30       Impact factor: 4.335

9.  Efficacious Analogs of the Lantibiotic Mutacin 1140 against a Systemic Methicillin-Resistant Staphylococcus aureus Infection.

Authors:  Mengxin Geng; Akshaya Ravichandran; Jerome Escano; Leif Smith
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

10.  Impact of nicotine metabolism on nicotine's pharmacological effects and behavioral responses: insights from a Cyp2a(4/5)bgs-null mouse.

Authors:  Lei Li; Kunzhi Jia; Xin Zhou; Sarah E McCallum; Lindsay B Hough; Xinxin Ding
Journal:  J Pharmacol Exp Ther       Date:  2013-09-17       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.